Pharmacophore modeling, virtual screening and docking studies to identify novel HNMT inhibitors

Pavadai Elumalai, Hsuan Liang Liu, Jian Hua Zhao, Wilson Chen, Dar Shong Lin, Chih Kuang Chuang, Wei Bor Tsai, Yih Ho

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Histamine N-methyltransferase (HNMT) is the key enzyme responsible for inactivating histamine in bronchus, kidney, and the central nervous system of mammals. The inhibition of HNMT has therapeutically potential roles in neurodegenerative disease, memory and learning deficits and attention-deficit hyperactivity disorder. For better understanding the essential chemical features for HNMT inhibition and identifying novel inhibitors, a three-dimensional (3D) chemical-feature-based QSAR pharmacophore model for HNMT inhibitors was first time developed using Discovery Studio 2.5. The best model (Hypo1), which has the highest correlation coefficient (0.96), the highest cost difference (74.51) and the lowest RMS (0.73. Å), consists two hydrophobic, one hydrophobic aromatic, one hydrogen bond acceptor and one hydrogen bond acceptor lipid. The reliability of Hypo1 was further validated using external test set, cost analysis, Fischer's randomization method and decoy data set. The validated Hypo1 was then used as a 3D search query for virtual screening to retrieve potential inhibitors from NCI database. Subsequently, the hit compounds were subjected to molecular docking studies with the crystal structure of HNMT. Finally, 10 hits were suggested as potential leads, which exhibited good estimated activities, favorable binding interactions, and high consensus scores. The obtained novel chemotype from this study may facilitate to discover a new scaffold for developing novel HNMT inhibitors.

Original languageEnglish
Pages (from-to)493-503
Number of pages11
JournalJournal of the Taiwan Institute of Chemical Engineers
Volume43
Issue number4
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Histamine N-Methyltransferase
Hydrogen bonds
Screening
Neurodegenerative diseases
Mammals
Studios
Neurology
Scaffolds
Lipids
Costs
Enzymes
Crystal structure
Data storage equipment
Histamine

Keywords

  • Consensus score
  • Histamine N-methyltransferase
  • Molecular docking
  • Pharmacophore model
  • Virtual screening

ASJC Scopus subject areas

  • Chemical Engineering(all)
  • Chemistry(all)

Cite this

Pharmacophore modeling, virtual screening and docking studies to identify novel HNMT inhibitors. / Elumalai, Pavadai; Liu, Hsuan Liang; Zhao, Jian Hua; Chen, Wilson; Lin, Dar Shong; Chuang, Chih Kuang; Tsai, Wei Bor; Ho, Yih.

In: Journal of the Taiwan Institute of Chemical Engineers, Vol. 43, No. 4, 07.2012, p. 493-503.

Research output: Contribution to journalArticle

Elumalai, Pavadai ; Liu, Hsuan Liang ; Zhao, Jian Hua ; Chen, Wilson ; Lin, Dar Shong ; Chuang, Chih Kuang ; Tsai, Wei Bor ; Ho, Yih. / Pharmacophore modeling, virtual screening and docking studies to identify novel HNMT inhibitors. In: Journal of the Taiwan Institute of Chemical Engineers. 2012 ; Vol. 43, No. 4. pp. 493-503.
@article{182f11700d634782927d7258d7010084,
title = "Pharmacophore modeling, virtual screening and docking studies to identify novel HNMT inhibitors",
abstract = "Histamine N-methyltransferase (HNMT) is the key enzyme responsible for inactivating histamine in bronchus, kidney, and the central nervous system of mammals. The inhibition of HNMT has therapeutically potential roles in neurodegenerative disease, memory and learning deficits and attention-deficit hyperactivity disorder. For better understanding the essential chemical features for HNMT inhibition and identifying novel inhibitors, a three-dimensional (3D) chemical-feature-based QSAR pharmacophore model for HNMT inhibitors was first time developed using Discovery Studio 2.5. The best model (Hypo1), which has the highest correlation coefficient (0.96), the highest cost difference (74.51) and the lowest RMS (0.73. {\AA}), consists two hydrophobic, one hydrophobic aromatic, one hydrogen bond acceptor and one hydrogen bond acceptor lipid. The reliability of Hypo1 was further validated using external test set, cost analysis, Fischer's randomization method and decoy data set. The validated Hypo1 was then used as a 3D search query for virtual screening to retrieve potential inhibitors from NCI database. Subsequently, the hit compounds were subjected to molecular docking studies with the crystal structure of HNMT. Finally, 10 hits were suggested as potential leads, which exhibited good estimated activities, favorable binding interactions, and high consensus scores. The obtained novel chemotype from this study may facilitate to discover a new scaffold for developing novel HNMT inhibitors.",
keywords = "Consensus score, Histamine N-methyltransferase, Molecular docking, Pharmacophore model, Virtual screening",
author = "Pavadai Elumalai and Liu, {Hsuan Liang} and Zhao, {Jian Hua} and Wilson Chen and Lin, {Dar Shong} and Chuang, {Chih Kuang} and Tsai, {Wei Bor} and Yih Ho",
year = "2012",
month = "7",
doi = "10.1016/j.jtice.2012.01.004",
language = "English",
volume = "43",
pages = "493--503",
journal = "Journal of the Taiwan Institute of Chemical Engineers",
issn = "1876-1070",
publisher = "Taiwan Institute of Chemical Engineers",
number = "4",

}

TY - JOUR

T1 - Pharmacophore modeling, virtual screening and docking studies to identify novel HNMT inhibitors

AU - Elumalai, Pavadai

AU - Liu, Hsuan Liang

AU - Zhao, Jian Hua

AU - Chen, Wilson

AU - Lin, Dar Shong

AU - Chuang, Chih Kuang

AU - Tsai, Wei Bor

AU - Ho, Yih

PY - 2012/7

Y1 - 2012/7

N2 - Histamine N-methyltransferase (HNMT) is the key enzyme responsible for inactivating histamine in bronchus, kidney, and the central nervous system of mammals. The inhibition of HNMT has therapeutically potential roles in neurodegenerative disease, memory and learning deficits and attention-deficit hyperactivity disorder. For better understanding the essential chemical features for HNMT inhibition and identifying novel inhibitors, a three-dimensional (3D) chemical-feature-based QSAR pharmacophore model for HNMT inhibitors was first time developed using Discovery Studio 2.5. The best model (Hypo1), which has the highest correlation coefficient (0.96), the highest cost difference (74.51) and the lowest RMS (0.73. Å), consists two hydrophobic, one hydrophobic aromatic, one hydrogen bond acceptor and one hydrogen bond acceptor lipid. The reliability of Hypo1 was further validated using external test set, cost analysis, Fischer's randomization method and decoy data set. The validated Hypo1 was then used as a 3D search query for virtual screening to retrieve potential inhibitors from NCI database. Subsequently, the hit compounds were subjected to molecular docking studies with the crystal structure of HNMT. Finally, 10 hits were suggested as potential leads, which exhibited good estimated activities, favorable binding interactions, and high consensus scores. The obtained novel chemotype from this study may facilitate to discover a new scaffold for developing novel HNMT inhibitors.

AB - Histamine N-methyltransferase (HNMT) is the key enzyme responsible for inactivating histamine in bronchus, kidney, and the central nervous system of mammals. The inhibition of HNMT has therapeutically potential roles in neurodegenerative disease, memory and learning deficits and attention-deficit hyperactivity disorder. For better understanding the essential chemical features for HNMT inhibition and identifying novel inhibitors, a three-dimensional (3D) chemical-feature-based QSAR pharmacophore model for HNMT inhibitors was first time developed using Discovery Studio 2.5. The best model (Hypo1), which has the highest correlation coefficient (0.96), the highest cost difference (74.51) and the lowest RMS (0.73. Å), consists two hydrophobic, one hydrophobic aromatic, one hydrogen bond acceptor and one hydrogen bond acceptor lipid. The reliability of Hypo1 was further validated using external test set, cost analysis, Fischer's randomization method and decoy data set. The validated Hypo1 was then used as a 3D search query for virtual screening to retrieve potential inhibitors from NCI database. Subsequently, the hit compounds were subjected to molecular docking studies with the crystal structure of HNMT. Finally, 10 hits were suggested as potential leads, which exhibited good estimated activities, favorable binding interactions, and high consensus scores. The obtained novel chemotype from this study may facilitate to discover a new scaffold for developing novel HNMT inhibitors.

KW - Consensus score

KW - Histamine N-methyltransferase

KW - Molecular docking

KW - Pharmacophore model

KW - Virtual screening

UR - http://www.scopus.com/inward/record.url?scp=84862778272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862778272&partnerID=8YFLogxK

U2 - 10.1016/j.jtice.2012.01.004

DO - 10.1016/j.jtice.2012.01.004

M3 - Article

AN - SCOPUS:84862778272

VL - 43

SP - 493

EP - 503

JO - Journal of the Taiwan Institute of Chemical Engineers

JF - Journal of the Taiwan Institute of Chemical Engineers

SN - 1876-1070

IS - 4

ER -